These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23034676)

  • 1. Exploiting FOXM1-orchestrated molecular network for early squamous cell carcinoma diagnosis and prognosis.
    Teh MT; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Purdie K; Harwood C; Wan H; Odell EW; Hackshaw A; Waseem A
    Int J Cancer; 2013 May; 132(9):2095-106. PubMed ID: 23034676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomas.
    Ma H; Dai H; Duan X; Tang Z; Liu R; Sun K; Zhou K; Chen H; Xiang H; Wang J; Gao Q; Zou Y; Wan H; Teh MT
    Oncotarget; 2016 Aug; 7(34):54555-54563. PubMed ID: 27409343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas.
    Hwang S; Mahadevan S; Qadir F; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Waseem A; Teh MT
    Cancer; 2013 Dec; 119(24):4249-58. PubMed ID: 24114764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
    Teh MT; Gemenetzidis E; Patel D; Tariq R; Nadir A; Bahta AW; Waseem A; Hutchison IL
    PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative study of epigenetic signature in head and neck squamous cell carcinoma.
    Umair A; Tarakji B; Ibrahim A; Nasser A; Fq A; Shreen A
    Turk J Med Sci; 2015; 45(2):372-86. PubMed ID: 26084130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.
    Gemenetzidis E; Bose A; Riaz AM; Chaplin T; Young BD; Ali M; Sugden D; Thurlow JK; Cheong SC; Teo SH; Wan H; Waseem A; Parkinson EK; Fortune F; Teh MT
    PLoS One; 2009; 4(3):e4849. PubMed ID: 19287496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Signatures of Tumour and Its Microenvironment for Precise Quantitative Diagnosis of Oral Squamous Cell Carcinoma: An International Multi-Cohort Diagnostic Validation Study.
    Teh MT; Ma H; Liang YY; Solomon MC; Chaurasia A; Patil R; Tekade SA; Mishra D; Qadir F; Yeung JS; Liu X; Kriuar S; Zhao R; Waseem A; Hutchison IL
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of differentially expressed genes in dysplastic oral keratinocyte cell line and their role in the development of HNSCC.
    Bs A; P A; As SG; A P; J VP
    J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(4S):101928. PubMed ID: 38815724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.
    Waseem A; Ali M; Odell EW; Fortune F; Teh MT
    Oral Oncol; 2010 Jul; 46(7):536-42. PubMed ID: 20400365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
    Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
    Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of SIRT1 and tumor suppressor gene TAp63 expression in head and neck squamous cell carcinoma.
    Kikuchi K; Noguchi A; Kasajima R; Miyagi Y; Hoshino D; Koshikawa N; Kubota A; Yokose T; Takano Y
    Tumour Biol; 2015 Sep; 36(10):7865-72. PubMed ID: 25946975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening key lncRNAs with diagnostic and prognostic value for head and neck squamous cell carcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
    Hu Y; Guo G; Li J; Chen J; Tan P
    Cancer Biomark; 2020; 27(2):195-206. PubMed ID: 31815689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.
    Liu CJ; Shen WG; Peng SY; Cheng HW; Kao SY; Lin SC; Chang KW
    Int J Cancer; 2014 Feb; 134(4):811-21. PubMed ID: 23824713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma.
    Ryu HJ; Kim EK; Heo SJ; Cho BC; Kim HR; Yoon SO
    APMIS; 2017 Nov; 125(11):974-984. PubMed ID: 28975663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of SIRT gene family in head and neck squamous cell carcinoma.
    Lai CC; Lin PM; Lin SF; Hsu CH; Lin HC; Hu ML; Hsu CM; Yang MY
    Tumour Biol; 2013 Jun; 34(3):1847-54. PubMed ID: 23475622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.
    Schröck A; Bode M; Göke FJ; Bareiss PM; Schairer R; Wang H; Weichert W; Franzen A; Kirsten R; van Bremen T; Queisser A; Kristiansen G; Heasley L; Bootz F; Lengerke C; Perner S
    Carcinogenesis; 2014 Jul; 35(7):1636-42. PubMed ID: 24743512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and neck cancer and precancer: can we use molecular genetics to make better predictions?
    Partridge M
    Ann R Coll Surg Engl; 1999 Jan; 81(1):1-11. PubMed ID: 10325677
    [No Abstract]   [Full Text] [Related]  

  • 20. Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor.
    De Cecco L; Bossi P; Locati L; Canevari S; Licitra L
    Ann Oncol; 2014 Aug; 25(8):1628-35. PubMed ID: 24827125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.